Kerry Read
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 12
- Infective Endocarditis Diagnosis and Management 10
- Burkholderia infections and melioidosis 2
-
- COVID-19 Clinical Research Studies 3
- Amoebic Infections and Treatments 1
- Co-authors
- Sally Roberts (3 shared papers)Andrew Fuller (1 shared paper)Philipp du Cros (1 shared paper)Peter B. Ward (1 shared paper)Tony M. Korman (1 shared paper)James C. Hurley (1 shared paper)M. Lindsay Grayson (1 shared paper)Narin Bak (1 shared paper)
- Journals
- The Lancet (3 papers)Clinical Infectious Diseases (3 papers)PLoS ONE (2 papers)Open Forum Infectious Diseases (2 papers)Infectious Diseases and Therapy (1 paper)
- Partner nations
- New ZealandAustraliaUnited States
In The Last Decade
Kerry Read
25 papers receiving 2.1k citations
Kerry Read's Hit Papers
Peers
Comparison fields: 5 of 98
- Infectious Diseases 1k
- Applied Microbiology and Biotechnology 76
- Epidemiology 532
- Internal Medicine 27
- Pharmacology 83
Countries citing papers authored by Kerry Read
This map shows the geographic impact of Kerry Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Read more than expected).
Fields of papers citing papers by Kerry Read
This network shows the impact of papers produced by Kerry Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Read. The network helps show where Kerry Read may publish in the future.
Co-authors
The 25 scholars most cited alongside Kerry Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 431 | |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | 2021 | 213 | |
| 5 | 2013 | 180 | |
| 6 | 2016 | 164 | |
| 7 | 2014 | 84 | |
| 8 | 2020 | 54 | |
| 9 | 2023 | 47 | |
| 10 | 2022 | 46 | |
| 11 | 2021 | 45 | |
| 12 | 2014 | 44 | |
| 13 | 2011 | 38 | |
| 14 | 2019 | 35 | |
| 15 | 2023 | 22 | |
| 16 | 2007 | 12 | |
| 17 | 2001 | 9 | |
| 18 | Infective endocarditis in New Zealand: data from the International Collaboration on Endocarditis Prospective Cohort Study. | 2014 | 8 |
| 19 | 2014 | 7 | |
| 20 | 2022 | 6 |
About Kerry Read
Kerry Read is a scholar working on Epidemiology, Infectious Diseases, Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine and Health Information Management, having authored 25 papers that have together received 2.2k indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (10 papers), COVID-19 Clinical Research Studies (3 papers), Orthopedic Infections and Treatments (2 papers), Burkholderia infections and melioidosis (2 papers), Streptococcal Infections and Treatments (1 paper), Amoebic Infections and Treatments (1 paper), Lysosomal Storage Disorders Research (1 paper) and Artificial Intelligence in Healthcare (1 paper). The work is most often cited by research in Infectious Diseases (1k citations), Applied Microbiology and Biotechnology (76 citations), Epidemiology (532 citations), Internal Medicine (27 citations) and Pharmacology (83 citations). Kerry Read has collaborated with scholars based in New Zealand, Australia and United States. Frequent co-authors include Sally Roberts, Andrew Fuller, Philipp du Cros, Peter B. Ward, Tony M. Korman, James C. Hurley, M. Lindsay Grayson, Narin Bak, Benjamin P. Howden and Jenny Robson. Their work appears in journals such as The Lancet, Clinical Infectious Diseases, PLoS ONE, Open Forum Infectious Diseases and Infectious Diseases and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.